Reference 2017-301

REF:            2017-301

Subject:        Intra-Vitreal Injection/Implants

    

 

Request:

Within your trust how many intra-vitreal injections/implants have been used in the latest 4 months, if possible between January and April 2017?

If your trust is able to identify injections/implants by eye conditions please split by the drug used [ranibizumab, bevacizumab, aflibercept, Fluocinolone and Dexamethasone].

 

 

Response:

  Lucentis (ranibizumab) Injections Avastin (bevacizumab) Injections Eylea (aflibercept) Injections Illuvien (Fluocinolone) Impants Ozudex (Dexamethasone) Implants
Total 960 0 664 0 19
We are unable to break the data down further by condition